Semaglutide and constipation: the straight facts

Simon Edward • 28 May 2025

Ready to start your weight loss journey? Download the free SemaPen app and find out if you're eligible in minutes.

Get Started Free

Are you experiencing constipation on Wegovy (semaglutide)? Learn why it happens and how to manage it.



Are you experiencing constipation on Wegovy (semaglutide)? Learn why it happens and how to manage it.

Wegovy is a highly effective weight loss medication with the active ingredient semaglutide. On average, people who undergo a full course of Wegovy treatment lose 15% of their starting body weight.


For people living with obesity, it can be a game-changer. However, like any medication, it comes with the risk of side effects.

Most Wegovy side effects are mild and get better with time. Some of the most common are nausea, vomiting, diarrhoea and – for around 24% of users – constipation.


The good news is that the constipation usually doesn't stick for long. But that doesn't change the fact it can be uncomfortable and annoying for those who experience it.


In this quick guide, we look at why semaglutide can sometimes cause constipation. We also share some sensible steps you can take to manage the symptoms of constipation or avoid it entirely.


Why can semaglutide cause constipation?


Semaglutide, the active ingredient in Wegovy, is a GLP-1 receptor agonist. It mimics a natural hormone that's involved in digestion.


One of its effects is slowing stomach emptying, so you feel full for longer. Losing weight becomes easier because you have a smaller appetite, feel satisfied with smaller portions and experience fewer food cravings.


This slowing down of the digestive process is probably why some users experience constipation.


See, food doesn't pass through the colon on its own. It moves because of a natural process called 'peristalsis' – waves of muscle contractions that flow through the gut.


When you take Wegovy, these muscle contractions aren't as strong. That means food moves more slowly and can build up in the colon.


As food sits in the colon, water is absorbed from it. If the food sticks around too long, it becomes dry, hard stool that's difficult to pass – one of the classic symptoms of constipation.


Constipation can also be accompanied by bloating and abdominal discomfort.


Tips for avoiding and managing constipation with Wegovy


1. Increase your dietary fibre

Eating a healthy amount of fibre is important for a number of reasons. Not only can it reduce the risk of several dangerous health conditions, but it also helps us maintain a regular toilet routine.


Picture of a bowl of full of fruit and fibre.

The NHS recommends that adults eat 30g of fibre daily.


There are two types of dietary fibre. If you have constipation on semaglutide, you should try to eat plenty of each.


  • Insoluble fibre adds bulk to stool and stimulates movement through the intestinal tract. Sources include vegetables, wheat bran, nuts, seeds and dried fruits.
  • Soluble fibre dissolves into a gel, which coats and softens stool. Good sources are oats, avocados, flaxseeds, beans, apples and pears.


The perfect combo would be a healthy oat granola bar with nuts, seeds and dried fruits. You could also try sprinkling a tablespoon of flaxseeds (linseeds) over your breakfast cereal or into yoghurt with chopped fruit.


It's important to increase fibre intake gradually. This allows your digestive system to process it effectively. If you eat too much fibre too quickly, you could make constipation worse. 


2. Increase your water intake. 


This goes hand-in-hand with increasing soluble fibre. Drinking fluids softens stool and helps it pass through the digestive tract. The NHS recommends drinking six to eight glasses of water a day.


3. Increase your activity


Regular exercise has numerous benefits to mental and physical health – including helping with constipation. Just 10 minutes of brisk walking each day will help stimulate the bowel wall to move stools along to the rectum.


What to do if things don't improve


For most Wegovy patients, constipation can be successfully managed. However, if the constipation does not improve with these measures, you should speak to your GP or healthcare provider. 


The NHS guidelines recommend you see your healthcare provider if you:


  • Are regularly constipated
  • Are regularly bloated
  • Have blood in your poo
  • Have lost weight without trying
  • Are constipated and tired all the time
  • Are taking medicine that's causing constipation
  • Notice sudden changes in the how you poo (your bowel habits)
  • Have tummy pain


SemaPen is a weight loss clinic founded and staffed by obesity treatment experts. For more advice on managing side effects, read our expert guides or visit our blog.


Sources


1. Wilding, J.P.H. et al. (2021) "Once-weekly semaglutide in adults with overweight or obesity" The New England Journal of Medicine, 384(11) https://doi.org/10.1056/NEJMoa2032183


2. https://www.novomedlink.com/obesity/products/treatments/wegovy/efficacy-safety/safety-profile.html


3. Marathe, C.S. et al. (2011) "Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function" Journal of Diabetes Research, 2011:279530 https://doi.org/10.1155/2011/279530


This article was reviewed and approved by Alice Fletcher, Lead Bariatric Dietician, and Lujain Alhassan, Bariatric Nutritionist, on 20 May 2025.


  • Average 15–21% weight loss
  • Trusted programmes built by UK experts
  • Personalised advice and support
  • Smart weight loss app to track progress and learn positive habits

Your journey starts in the app

Unlock tailored support, weight tracking and more.

1

Download the free app

2

Take your digital consultation

3

Start your programme

Download the app
Doctors look at several things when prescribing Wegovy. Find out what questions you'll be asked
by Simon Edward 2 March 2026
Doctors look at several things when prescribing Wegovy. Find out what questions you'll be asked – and why.
Metabolic syndrome is a cluster of conditions that can lead to complications like type 2 diabetes.
by Simon Edward 27 February 2026
Metabolic syndrome is a cluster of conditions that can lead to complications like type 2 diabetes. Could Mounjaro help treat it? Let's find out.
Have you noticed itchiness when taking Wegovy (semaglutide)? Learn what's normal
by Simon Edward 23 February 2026
Have you noticed itchiness when taking Wegovy (semaglutide)? Learn what's normal and when to be concerned.
There's a strong link between obesity and hypertension (high blood pressure). But what causes it?
by Simon Edward 20 February 2026
There's a strong link between obesity and hypertension (high blood pressure). But what causes it? And what can you do to lower your risk?
Mounjaro can be a big helping hand for weight loss – but that doesn't mean you can eat anything
by Simon Edward 16 February 2026
Mounjaro can be a big helping hand for weight loss – but that doesn't mean you can eat anything and still lose weight. Learn what dieticians recommend.
Several new weight loss treatments are in development, including Amgen's MariTide. Get the key facts
by Simon Edward 13 February 2026
Several new weight loss treatments are in development, including Amgen's MariTide. Get the key facts about this US-made injectable medication.
Are you considering using Wegovy for weight loss? Read our beginner's guide
by Simon Edward 9 February 2026
Are you considering using Wegovy for weight loss? Read our beginner's guide to get the key information you need in one place.
Did you know that extreme calorie-cutting can make losing weight more difficult? Learn why –
by Simon Edward 6 February 2026
Did you know that extreme calorie-cutting can make losing weight more difficult? Learn why – and what to do instead.
Clinical trials have shown that Mounjaro is safe and effective as a treatment for obesity
by Simon Edward 2 February 2026
Clinical trials have shown that Mounjaro is safe and effective as a treatment for obesity and type 2 diabetes. Let's explore their findings in more detail.
Discover more about the FLOW study semaglutide trial, which looked at how Wegovy could lower risks
by Simon Edward 31 January 2026
Discover more about the FLOW study semaglutide trial, which looked at how Wegovy could lower risks in people with chronic kidney disease.
More posts